Menu
Not yet recruiting NCT07450677

Sensory Substitution and Brain Plasticity Following Vision Loss

No phase Interventional Blindness

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Electrotactile display (BrainPort), Vision-to-sound converter (AI Sight), Sham.
Who it may be relevant to
Registry conditions: Blindness. Basic parameters: 8 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Neurobehavioral Effects of Visual Assistive Technologies

Overview

The goal of this clinical investigation is to learn how the brain responds when visual information is converted into patterns of sound or touch in blind and sighted participants. The main questions it aims to answer are: * Does converting visual information into sound or touch patterns change visual performance in the blind or blindfolded? * How does the brain adapt to different kinds of sensory information? Researchers will use brain imaging and simple performance tasks to see how people process and learn from this type of converted sensory input. The investigators will compare how individuals with and without long-term vision loss respond to these signals. Participants will: * Learn to use technologies to assist in visual information conversion into sound or touch patterns every day for 5 weeks; * Visit the brain imaging center 3 times for brain scans and behavioral tests.

Interventions

  • Device Electrotactile display (BrainPort)
    The BrainPort is a non-surgical assistive device that translates digital information from a video camera to gentle electrotactile stimulation patterns on the surface of the tongue.
  • Device Vision-to-sound converter (AI Sight)
    The AI Sight is an auditory technology software that can convert visual information into sound patterns, which can be delivered through regular headphones.
  • Device Sham
    Participants will wear the assistive technology system, but there will be no active sensory signals applied.

Primary outcome measures

  • Number of correct responses to visual performance tasks [Time frame: 5 weeks]
  • Reaction time to visual performance tasks [Time frame: 5 weeks]
  • Metabolic brain profile [Time frame: 5 weeks]
  • Blood-oxygenation-level-dependent functional brain activity level [Time frame: 5 weeks]
Secondary outcome measures (2)
  • Gray matter density [Time frame: 5 weeks]
  • White matter directional diffusivity [Time frame: 5 weeks]

Eligibility criteria

Inclusion criteria

  • 8-85 years old for blind individuals; or 18-85 years old for sighted controls.
  • (a) Blind due to ocular impairment (documented visual acuity of light perception or worse) in both eyes, or (b) sighted healthy adult controls with corrected visual acuity of 20/40 or better and with no known vision disorders.
  • Able to hear the Informed Consent Form being read out to him or her, to understand it, and sign the Informed Consent Form.
  • Able to undergo functional neuroimaging tests.
  • Able to walk and stand independently.
  • Able to understand and remember the training protocols involved in the research study.
  • Willing and able to use the provided sensory substitution system to solve simple visual tasks.
  • Willing and able to complete simple tactile or auditory tasks.
  • Able to communicate by telephone and/or computer with research staff.

Exclusion criteria

  • Prior use with the sensory substitution device under investigation. This applies to both the auditory and tactile stimulators.
  • Presence of any foreign metal in the body, except for dental fillings (will need to be pre-screened by a radiologist prior to signing the informed consent and enrollment).
  • Pregnant or breastfeeding by self-report or urine test.
  • Is a prisoner or has any required movements legally restricted.
  • Unwilling or unable to adhere to all study requirements, including completion of the training period and any evaluation tests.
  • Implanted electrical medical devices such as pacemakers.
  • Claustrophobia that would prevent functional neuroimaging.
  • Obesity preventing placement in the MRI scanner.
  • No known neurological disorders or any medical condition that can possibly lead to emergency medical care (e.g., history of seizures, family history of epilepsy, stroke, severe headaches, use of medication for neurological or psychiatric conditions).
  • Documented or suspected brain damage resulting in significant cognitive or sensory impairment (e.g., traumatic brain injury).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Basic science

Study locations

United States · 2 centers
  • Byers Eye Institute at Stanford University — Palo Alto
  • LUCAS Center for Imaging — Stanford

Identifiers

NCT: NCT07450677 · 80671 · R01EY034897

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗